pms-selegiline tablet
pharmascience inc - selegiline hydrochloride - tablet - 5mg - selegiline hydrochloride 5mg - monoamine oxidase b inhibitors
selegilina eg
eg s.p.a. - selegilina - selegilina
selegilina
sandoz s.p.a. - selegilina - selegilina
selegilina dorom
dorom s.r.l. - selegilina - selegilina
selegiline hydrochloride tablet
a-s medication solutions - selegiline hydrochloride (unii: 6w731x367q) (selegiline - unii:2k1v7gp655) - selegiline hydrochloride tablets usp are indicated as an adjunct in the management of parkinsonian patients being treated with levodopa/carbidopa who exhibit deterioration in the quality of their response to this therapy. there is no evidence from controlled studies that selegiline has any beneficial effect in the absence of concurrent levodopa therapy. evidence supporting this claim was obtained in randomized controlled clinical investigations that compared the effects of added selegiline or placebo in patients receiving levodopa/carbidopa. selegiline was significantly superior to placebo on all three principal outcome measures employed: change from baseline in daily levodopa/carbidopa dose, the amount of 'off' time, and patient self-rating of treatment success. beneficial effects were also observed on other measures of treatment success (e.g., measures of reduced end of dose akinesia, decreased tremor and sialorrhea, improved speech and dressing ability and improved overall disability as assessed by walking
selegilin 5 mg gerard tablette
mcdermott laboratories limited t/a gerard laboratories, t/a mylan dublin, t/a mylan dublin respiratory, t/a mylan dublin biologi - selegilinhydrochlorid - tablette - selegilinhydrochlorid 5.mg
selegilin-merz tablette
merz pharmaceuticals gmbh - selegilinhydrochlorid - tablette - selegilinhydrochlorid 5.mg
selegilin taurus tablette
taurus pharma gmbh - selegilinhydrochlorid - tablette - selegilinhydrochlorid 5.mg
selegilin sandoz 5mg tabletten
sandoz pharmaceuticals gmbh - selegilinhydrochlorid - tablette - selegilinhydrochlorid 5.mg
selegilin iip lösung lösung zum einnehmen
iip - institut für industrielle pharmazie forschungs- und entwicklungsgesellschaft mbh - selegilinhydrochlorid - lösung zum einnehmen - selegilinhydrochlorid 1.mg